{"wiki_id": "http://www.wikidata.org/entity/Q4730491", "itemLabel": "Allan Bradley", "itemDescription": "geneticist", "wikipedia_url": "https://en.wikipedia.org/wiki/Allan_Bradley", "wikipedia_page": {"main": "Allan Bradley FRS is a British geneticist at the Wellcome Trust Sanger Institute.", "link_mentions": [{"page": "Wellcome Sanger Institute", "response": ["In 2000, Allan Bradley left his appointment as professor at the Baylor College of Medicine, in the US, to take up the position as director of the Sanger Institute. Bradley wanted to build on the achievements made by the Sanger Institute in the Human Genome Project by \"concentrating on gene function, cancer genomics, and the genomes of model organisms such as the mouse and the zebrafish\". Bradley received his BA, MA and PhD in Genetics from the University of Cambridge."]}, {"page": "Lexicon Pharmaceuticals", "response": ["Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's postdoctoral fellow Arthur T Sands. The company has used its patented mouse gene knockout technology and extensive in vivo screening capabilities to study nearly 5,000 genes in its Genome5000 program and has identified over 100 potential therapeutic targets. Lexicon has advanced multiple drug candidates into human clinical trials and has a broad and diverse pipeline of drug targets behind its clinical programs.  Lexicon is pursuing drug targets in five therapeutic areas including oncology, gastroenterology, immunology, metabolism, and ophthalmology."]}, {"page": "Searle Scholars Program", "response": ["* Allan Bradley, Baylor College of Medicine"]}, {"page": "List of fellows of the Royal Society A, B, C", "response": ["| Allan Bradley||09/05/2002||"]}, {"page": "Michael Stratton", "response": ["Stratton has held clinical posts at Guy's Hospital, Westminster Hospital, Hammersmith Hospital and the Royal Marsden Hospital. He took up a Faculty appointment and now holds a Professorship at the Institute of Cancer Research. He joined the Sanger Institute in 2000 and was promoted to deputy director in 2007. In May 2010, he was appointed director, succeeding Allan Bradley."]}, {"page": "Alan Bradley", "response": ["*Allan Bradley, British geneticist"]}, {"page": "List of fellows of the Royal Society elected in 2002", "response": ["#Allan Bradley"]}]}}